Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 7, 2008, Pages 2993-3003

  Polak, Marianne Berdugo ^a   Valamanesh, Fatemeh ^a,b   Felt, Olivia ^c   Torriglia, Alicia ^a   Jeanny, Jean Claude ^a   Bourges, Jean Louis ^a,d   Rat, Patrice ^e   Thomas Doyle, Aoife ^a   Benezra, David ^a,f   Gurny, Robert ^c   Behar Cohen, Francine ^a,d  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d HÔTEL DIEU   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLOROURACIL DERIVATIVE; APOPTOSIS INDUCING FACTOR; DEOXYRIBONUCLEASE I; FLUOROURACIL; LEUKOCYTE ELASTASE INHIBITOR; LIPOCORTIN 5; MONOTETRAZOLIUM; NEUTRAL RED; POLY(ORTHO ESTER); TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG; 5-CHLOROURACIL; ANTIMITOTIC AGENT; CHLOROURACIL; DRUG DERIVATIVE; POLYMER; URACIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL DEATH; CELL ISOLATION; CONJUNCTIVA; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; EYE; FEMALE; FIBROBLAST; FILTERING OPERATION; GLAUCOMA; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; METASTASIS INHIBITION; MITOSIS INHIBITION; NICK END LABELING; NONHUMAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; TRABECULECTOMY; ANIMAL; BLISTER; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; INJECTION; METHODOLOGY; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIMITOTIC AGENTS; APOPTOSIS; BLISTER; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHROMATIN; CONJUNCTIVA; DRUG DELIVERY SYSTEMS; FEMALE; FIBROBLASTS; FILTERING SURGERY; FLUOROURACIL; GLAUCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS; INTRAOCULAR PRESSURE; NECROSIS; POLYMERS; RABBITS; TRABECULECTOMY; URACIL;

EID: 48249119618     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0919     Document Type: Article

References (56)

1. Rivera AH, Hajek AS, Fantes F, Mallick KS, Parrish RK. Trifluorothymidine and 5-fluorouracil: antiproliferative activity in tissue culture. Can J Ophthalmol. 1987;22:13-16. (Pubitemid 17028203)
2. Wong VK, Shapourifar-Tehrani S, Kitada S, Choo PH, Lee DA. Inhibition of rabbit ocular fibroblast proliferation by 5-fluorouracil and cytosine arabinoside. J Ocul Pharmacol. 1991;7:27-39.
3. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon capsule fibroblasts. Ophthalmology. 1992;99:1471-1476.
4. Saika S, Ooshima A, Yamanaka O, et al. In vitro effects of doxorubicin and mitomycin C on human Tenon capsule fibroblasts. Ophthalmic Res. 1997;29:91-102. (Pubitemid 27197047)
5. Lee DA, Shapourifar-Tehrani S, Stephenson TR, Kitada S. The effects of the fluorinated pyrimidines FUR, FUdR, FUMP, and FdUMP on human Tenon fibroblasts. Invest Ophthalmol Vis Sci. 1991;32:2599-2609.
6. Smyth RJ, Moore JJ, Shapourifar-Tehrani S, Lee DA. The effects of 5-fluorouridine, 5-fluorodeoxyuridine, and 5-fluorodeoxyuridine monophosphate on rabbit Tenon capsule fibroblasts in vitro. J Ocul Pharmacol. 1991;7:329-338.
7. Heath TD, Lopez NG, Lewis GP, Stern WH. Antiproliferative and anticontractile effects of liposome encapsulated fluoroorotate. Invest Ophthalmol Vis Sci. 1987;28:1365-1372. (Pubitemid 17161244)
8. Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NS. The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:2043-2052.
9. Oguz H. Effectiveness of octreotide, an antiproliferative agent, on wound healing reaction after glaucoma surgery in an experimental rabbit model. Int Ophthalmol. 2004;25:185.
10. Al-Aswad LA, Huang M, Netland PA. Inhibition of Tenon fibroblast proliferation and enhancement of filtration surgery in rabbits with cytosine arabinoside. J Ocul Pharmacol Ther. 1999;15:41-49. (Pubitemid 29072592)
11. Akman A, Bilezikci B, Kucukerdonmez C, Demirhan B, Aydin P. Suramin modulates wound healing of rabbit conjunctiva after trabeculectomy: comparison with mitomycin C. Curr Eye Res. 2003;26:37-43. (Pubitemid 37467869)
12. Singh K, Mehta K, Shaikh NM, et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil: prospective randomized clinical trial. Ophthalmology. 2000;107:2305-2309.
13. Yoon PS, Singh K. Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and combined cataract and glaucoma surgery. Curr Opin Ophthalmol. 2004;15:141-146. (Pubitemid 38457135)
14. Sihota R, Dada T, Gupta SD, Sharma S, Arora R, Agarwal HC. Conjunctival dysfunction and mitomycin C-induced hypotony. J Glaucoma. 2000;9:392-397. (Pubitemid 32472307)
15. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology. 2002;109: 1336-1341; discussion 1341-1342. (Pubitemid 34700927)
16. Hernandez-Galilea E, Sanchez F, Guzman K, Moro MJ, Vazquez R, Barahona JM. [Effect of mitomycin C on corneal endothelium cells: in vitro study]. Arch Soc Esp Oftalmol. 2000;75:515-521.
17. Five-year follow-up of the Fluorouracil Filtering Surgery Study: the Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol. 1996;121:349-366.
18. Hartmann KU, Heidelberber C. Studies on fluorinated pyrimidines, XIII: inhibition of thymidylate synthetase. J Biol Chem. 1961;236: 3006-3013.
19. Durak I, Ozbek Z, Yaman A, Soylev M, Cingil G. The role of needle revision and 5-fluorouracil application over the filtration site in the management of bleb failure after trabeculectomy: a prospective study. Doc Ophthalmol. 2003;106:189-193. (Pubitemid 36355960)
20. Carassa RG, Bettin P, Fiori M, Brancato R. Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial. Ophthalmology. 2003;110: 882-887. (Pubitemid 36560483)
21. Libre PE. Transient, profound cataract associated with intracameral 5-fluorouracil. Am J Ophthalmol. 2003;135:101-102. (Pubitemid 36020437)
22. Lockshin RA, Zakeri Z. Apoptosis, autophagy, and more. Int J Biochem Cell Biol. 2004;36:2405-2419. (Pubitemid 39119755)
23. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol. 2006;6:308-317.
24. O'Connell AR, Stenson-Cox C. A more serine way to die: defining the characteristics of serine protease-mediated cell death cascades. Biochim Biophys Acta. 2007;1773:1491-1499. (Pubitemid 47500175)
25. Hail NJ, Carter BZ, Konopleva M, Andreeff M. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis. 2006;11:889-890. (Pubitemid 43880261)
26. Zignani M, Einmahl S, Baeyens V, et al. A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release. Eur J Pharm Biopharm. 2000;50:251-255. (Pubitemid 30674337)
27. Einmahl S, Behar-Cohen F, D'Hermies F, et al. A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery. Invest Ophthalmol Vis Sci. 2001;42:695-700. (Pubitemid 32206910)
28. Einmahl S, Ponsart S, Beijani RA, et al. Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation. J Biomed Mater Res. 2003;67:44-53. (Pubitemid 37517153)
29. Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudoin C. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctiva cells. Invest Ophthalmol Vis Sci. 2001;42:642-652. (Pubitemid 32206903)
30. Rat P, Korwin-Zmijowska C, Warnet JM, Adolphe M. New in vitro fluorimetric microtitration assays for toxicological screening of drugs. Cell Biol Toxicol. 1994;10:329-337. (Pubitemid 24377307)
31. Baudouin C, Pisella PJ, Goldschild M, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;105:556-563. (Pubitemid 30191592)
32. Debbasch C, Pisella PJ, Rat P, Warnet JM, Baudouin C. Evaluation de la cytotoxicité de trois substituts lacrimaux utilisés dans le traitement des syndromes secs. J Fr Ophtalmol. 2000;23:863-869. (Pubitemid 30842247)
33. Belloc F, Dumain P, Boisseau MR, et al. A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle and apoptosis determination in unfixed cells. Cytometry. 1994;17:59-65. (Pubitemid 24274205)
34. Debbasch C, Pisella PJ, De Saint Jean M, Rat P, Warnet JM, Baudoin C. Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved β-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42: 2525-2533. (Pubitemid 32954858)
35. Bourges JL, Valamanesh F, Torriglia A, et al. Cornea graft endothelial cells undergo apoptosis by way of an alternate (caspase-independent) pathway. Transplantation. 2004;78:316-323. (Pubitemid 39095395)
36. + antiport inhibition activates the LEI/L-DNase II pathway. Cell Death Differ. 2003;10:548-557.
37. Daugas E, Susin A, Zamzani M, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 2000;14:729-739. (Pubitemid 30198571)
38. Schwach-Abdellaoui K, Heller J, Gurny R. Synthesis and characterization of self-catalyzed poly(ortho esters) based on decanediol and decanediol-lactate. J Biomater Sci Polymer Edn. 1999;10:375-389. (Pubitemid 29106305)
39. Schwach-Abdellaoui K, Gurny R, Heller J, Barr J. 7 (1-2), Control of molecular weight for auto-catalyzed poly(ortho ester) obtained by polycondensation reaction. Int J Polymer Anal Characterization. 2002;7:145-161.
40. Sintzel MB, Heller J, Ng SY, Taylor MS, Tabatabay C, Gurny R. Synthesis and characterization of self-catalyzed poly(ortho esters). Biomaterials. 1998;19:791-800. (Pubitemid 28276630)
41. Zignani M, Bernatchez SB, Le Minh T, Tabatabay C, Anderson JM, Gurny R. Subconjunctival biocompatibility of a viscous nioerodible poly(ortho ester). J Biomed Mater Res. 1998;39:277-285. (Pubitemid 28060361)
42. Merkli A, Heller J, Tabatabay C, Gurny R. Semi-solid hydrophobic bioerodible poly(ortho ester) for potential application in glaucoma filtering surgery. J Control Release. 1998;55:213-218.
43. Heller J. Ocular delivery using poly(ortho esters). Adv Drug Deliv Rev. 2005;57:2053-2062. (Pubitemid 41740796)
44. Perkins TW, Faha B, Ni M, et al. Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol. 2002;120:941-949. (Pubitemid 34755547)
45. Torriglia A, Perani P, Brossas JY, et al. L-DNase II, a molecule that links proteases and endonucleases in apoptosis, derives from the ubiquitous serpin leukocyte elastase inhibitor. Mol Cell Biol. 1998; 18:3612-3619. (Pubitemid 28240534)
46. Boujrad H, Gubkina O, Robert N, Krantic S, Susin SA. AIF-mediated programmed necrosis a highly regulated way to die. Cell Cycle. 2007;6:2612-2619. (Pubitemid 350224042)
47. Chaudun E, Arruti C, Courtois Y, et al. DNA strand breakage during physiological apoptosis of the embryonic chick lens: free 3′ OH end single strand breaks do not accumulate even in the presence of a cation-independent deoxyribonuclease. J Cell Physiol. 1994; 158:354-364. (Pubitemid 24983400)
48. Torriglia A, Chaudun E, Chany-Fournier F, Jeanny JC, Courtois Y, Counis MF. Involvement of DNase II in nuclear degeneration during lens cell differentiation. J Biol Chem. 1995;270:28579-28585.
49. Counis MF, Torriglia A. Acid DNases and their interest among apoptotic endonucleases. Biochimie (Paris). 2006;88:1851-1858. (Pubitemid 44881186)
50. Khaw PT, Doyle JW, Sherwood MB, Smith MF, McGorray S. Effects of intraoperative 5-FU on glaucoma filtration surgery in the rabbit. Ophthalmology. 1993;100:367-372.
51. Kondo M, Araie M. Concentration change of fluorouracil in the external segment of the eye after subconjunctival injection. Arch Ophthalmol. 1988;106:1718-1721. (Pubitemid 19000137)
52. Chaudhry IA, Pasha MA, O'Connor DJ, Weitzman ML, Caprioli J. Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Am J Ophthalmol. 2000;130:700-703. (Pubitemid 32000849)
53. Jampel HD, Leong KW, Dunkelburger GR, Quigley HA. Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride disks. Arch Ophthalmol. 1990;108:430-435. (Pubitemid 20100698)
54. Lee DA, Leong KW, Panek WC, Eng CT, Glasgow BJ. The use of bioerodible polymers and 5-fluorouracil in glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 1988;29:1692-1697. (Pubitemid 18276220)
55. Hostyn P, Villain F, Malek-Chehire N, et al. [Biodegradable controlled- release 5-FU implant in the surgery for glaucoma: experimental study]. J Fr Ophtalmol. 1996;19:133-139.
56. Akimoto M, Miyahara T, Arai J, et al. A new delivery system for 5-fluorouracil using prodrug and converting enzyme. Br J Ophthalmol. 2002;86:581-586. (Pubitemid 34454507)